Work

Antithrombotic and Thrombolytic Therapy for Ischemic Stroke

Year: 1998

Type: review

Abstract: Ischemic stroke is a syndrome, and the optimal use of antithrombotic therapies for stroke treatment or prevention is guided by the specific pathogenesis (Figs 1–2). Patients who are at increased risk for ischemic stroke can be identified (Fig 3). atherosclerosis of the arteries, large and small, that supply the brain is the most common cause of ischemic stroke in North America and Europe. atherosclerosis of the proximal aorta is also a source of atherogenic brain emboli. Large artery atherosclerotic infarction occurs when there is an impediment to normal perfusion, usually caused by a severe arterial stenosis or occlusion due to atherosclerosis and coexisting thrombosis.

Source: CHEST Journal

DOI: 10.1378/chest.114.5_supplement.683s

Authors: Gregory W. Albers, J. Donald Easton, Ralph L. Sacco, Philip Teal

Institutions: Stanford Medicine, Brown University, University of Miami, University of British Columbia

Language: English

Topic: Acute Ischemic Stroke Management

Subfield: Clinical Neurology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: hybrid

Estimated APC paid: $4,160